MYM Neutraceuticals Inc.

(CSE:MYM) (OTC:MYMMF) (FRA:0MY)

Company Description:

MYM Neutraceuticals Inc. is currently building three large-scale production facilities in both Canada and Australia. Upon completion of these three projects, the total amount of greenhouse growing space will exceed 2.5 million square feet.

Latest News & Stories on MYM Neutraceuticals Inc. (CSE:MYM) (OTC:MYMMF) (FRA:0MY)

MYM and Dutch Passion to Distribute Cannabis Seeds in Colombia

August 8, 2018

MYM Partners With Dutch Passion in Australia

August 1, 2018

MYM Shelves Automatic Securities Disposition Plan

July 12, 2018

MYM to Acquire 49% Stake in Colombian Cannabis Company

July 10, 2018

MYM and Sherbrooke Historical to Create CannaCentre Museum

July 6, 2018

MYM Nutraceuticals and Sherbrooke College Sign Partnership

June 28, 2018

MYM Finalizes the Purchase of 329 Acres of Land for Weedon Facility

June 5, 2018

MYM Breaks Ground on 1.5 Million Square Foot Weedon, Quebec Project

May 14, 2018

MYM Boosts Management Team, Announces Key New Hires

April 30, 2018

MYM Appoints New Chief Science Officer

March 7, 2018

MYM Receives Approval to Construct 1.5 Million Square Foot Facility

March 5, 2018

Solaris Nutraceuticals Receives $2,500,000 AUD Grant for Greenhouse

February 15, 2018

The Economic Impact of MYM's Weedon, Quebec Project

February 1, 2018

MYM Signs MOU With Colombian Medical Cannabis Company

January 22, 2018

MYM Adopts Automatic Plan for Insiders to Sell Their Shares

December 29, 2017

MYM Australia Project Announces Application Acceptance

December 21, 2017

PUF Ventures & MYM to Build Massive Australian Production Facility

October 30, 2017

MYM Neutraceuticals Switches Up its Board of Directors

October 25, 2017

The CSE Launches New CSE25 Index for Largest Listed Companies

September 19, 2017

MYM to Build 1.5 Million Square Foot Greenhouse in Québec

June 20, 2017

30+ Marijuana Companies Included in CSE Composite Index

May 16, 2017

MYM Nutraceuticals Appoints New CEO

April 28, 2017

MYM Nutraceuticals Closes HempMed Acquisition

April 11, 2017

MYM Neutraceuticals Prepares for Health Canada Pre-License Inspection

March 28, 2017

Please reload

DMO

© Copyright 2016-2020 Smoke Show Ventures, Inc.

RSS Feed

Disclaimer: Except for the historical information and data presented herein, matters discussed in articles on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future performance or achievements expressed or implied by such coverage. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. Before making specific investment decisions, readers should seek their own professional advice and that of their own professional financial adviser. Smoke Show Ventures, Inc. or its affiliates, which owns The Daily Marijuana Observer, may be compensated for its services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.dailymarijuanaobserver.com/legal-disclaimer/.